PH26380A - The use of 3'-deoxythymidin-2'-ene-2',3-didehydro-thymidine) in treating patients infected with retroviruses - Google Patents

The use of 3'-deoxythymidin-2'-ene-2',3-didehydro-thymidine) in treating patients infected with retroviruses Download PDF

Info

Publication number
PH26380A
PH26380A PH35869A PH35869A PH26380A PH 26380 A PH26380 A PH 26380A PH 35869 A PH35869 A PH 35869A PH 35869 A PH35869 A PH 35869A PH 26380 A PH26380 A PH 26380A
Authority
PH
Philippines
Prior art keywords
ene
deoxythymidin
retrovirus
diluent
admixture
Prior art date
Application number
PH35869A
Other languages
English (en)
Inventor
Tai-Shun Lin
William H Prusoff
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25478432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH26380(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Yale filed Critical Univ Yale
Publication of PH26380A publication Critical patent/PH26380A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH35869A 1986-12-17 1987-09-29 The use of 3'-deoxythymidin-2'-ene-2',3-didehydro-thymidine) in treating patients infected with retroviruses PH26380A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/942,666 US4978655A (en) 1986-12-17 1986-12-17 Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses

Publications (1)

Publication Number Publication Date
PH26380A true PH26380A (en) 1992-06-01

Family

ID=25478432

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35869A PH26380A (en) 1986-12-17 1987-09-29 The use of 3'-deoxythymidin-2'-ene-2',3-didehydro-thymidine) in treating patients infected with retroviruses

Country Status (22)

Country Link
US (1) US4978655A (cs)
EP (1) EP0273277B1 (cs)
JP (1) JPH07116041B2 (cs)
KR (1) KR960000433B1 (cs)
AT (1) ATE77554T1 (cs)
AU (1) AU593405B2 (cs)
CA (1) CA1293447C (cs)
DE (1) DE3780016T2 (cs)
DK (1) DK174627B1 (cs)
EG (1) EG19157A (cs)
ES (1) ES2038650T3 (cs)
FI (1) FI875544L (cs)
GR (1) GR3005691T3 (cs)
HK (1) HK55896A (cs)
IE (1) IE60866B1 (cs)
IL (1) IL84790A (cs)
LU (1) LU88822I2 (cs)
NL (1) NL960024I2 (cs)
NZ (1) NZ222935A (cs)
PH (1) PH26380A (cs)
PT (1) PT86346B (cs)
ZA (1) ZA877171B (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
CA2189097A1 (en) 1995-11-15 1997-05-16 Pin-Fang Lin Composition and method of treating retroviral infection
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
WO2000016625A1 (en) * 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Antiviral drug compositions containing lithium inorganic salts
GEP20043285B (en) * 2000-03-30 2004-07-26 Bristol Myers Squibb Co Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
PL219609B1 (pl) 2003-02-19 2015-06-30 Masanori Baba Analogi nukleozydów przeciwwirusowych, zawierająca je kompozycja farmaceutyczna i ich zastosowania
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
WO2006110157A2 (en) 2004-07-27 2006-10-19 Gilead Sciences, Inc. Nucleoside phosphonate conjugates as anti hiv agents
AU2006286314A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
CN102272134B (zh) 2008-12-09 2013-10-16 吉里德科学公司 Toll样受体调节剂
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
KR102019572B1 (ko) 2014-07-11 2019-09-06 길리애드 사이언시즈, 인코포레이티드 Hiv의 치료를 위한 톨-유사 수용체의 조정제
EP3349757A1 (en) 2015-09-15 2018-07-25 Gilead Sciences, Inc. Modulators of toll-like recptors for the treatment of hiv

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
JPS5943550B2 (ja) * 1975-08-29 1984-10-23 田辺製薬株式会社 不飽和ヌクレオシドの製法
DE3515870A1 (de) * 1985-05-03 1986-11-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 5-fluortoluol-2,4-disulfochlorid
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
NL8700089A (nl) * 1987-01-15 1988-08-01 Stichting Rega V Z W Therapeutische toepassing van dideoxythymidine en dideoxythymidineen.
DE3806633A1 (de) * 1987-09-01 1989-03-09 Bayer Ag Antivirales mittel
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
JPH0227782A (ja) * 1988-07-15 1990-01-30 Hikari Gijutsu Kenkyu Kaihatsu Kk 半導体発光素子
JPH0438727A (ja) * 1990-06-04 1992-02-07 Sharp Corp 光学式ピックアップ装置の対物レンズ塵埃付着防止機構

Also Published As

Publication number Publication date
EP0273277A3 (en) 1989-09-13
KR880007079A (ko) 1988-08-26
AU8090087A (en) 1988-06-23
FI875544A7 (fi) 1988-06-18
EP0273277B1 (en) 1992-06-24
PT86346B (pt) 1990-11-07
AU593405B2 (en) 1990-02-08
US4978655A (en) 1990-12-18
DE3780016T2 (de) 1992-12-24
IE873245L (en) 1988-06-17
ZA877171B (en) 1988-03-24
IE60866B1 (en) 1994-08-24
FI875544L (fi) 1988-06-18
JPH07116041B2 (ja) 1995-12-13
ATE77554T1 (de) 1992-07-15
DK174627B1 (da) 2003-07-28
DK557087D0 (da) 1987-10-23
EG19157A (en) 1994-09-29
PT86346A (en) 1988-01-01
NZ222935A (en) 1990-09-26
FI875544A0 (fi) 1987-12-16
GR3005691T3 (cs) 1993-06-07
KR960000433B1 (ko) 1996-01-06
LU88822I2 (fr) 1997-01-06
NL960024I1 (nl) 1996-12-02
HK55896A (en) 1996-04-03
DK557087A (da) 1988-06-18
IL84790A0 (en) 1988-05-31
CA1293447C (en) 1991-12-24
ES2038650T3 (es) 1993-08-01
DE3780016D1 (de) 1992-07-30
IL84790A (en) 1993-03-15
EP0273277A2 (en) 1988-07-06
JPS63215632A (ja) 1988-09-08
NL960024I2 (nl) 1997-06-02

Similar Documents

Publication Publication Date Title
US4978655A (en) Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4681933A (en) 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4841039A (en) 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
FI93111C (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
AU598575B2 (en) Retrovirus treatments
JPS61280500A (ja) ヌクレオシド化合物
EP0322384A1 (en) Nucleosides for use in therapy
US4710492A (en) 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
EP0261595B1 (en) Pharmaceutical composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-didehydrocytidine) for treating patients infected with retrovirus
US5215971A (en) Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
US5190926A (en) 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents
US5446029A (en) Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
US4999360A (en) Method of inhibiting virus
JPH0240369A (ja) 新規なネプラノシン誘導体類
WO1988004662A1 (en) Use of nucleosides for the manufacture of medicament for treatment of diseases caused by retrovirus or hepatitis b virus
US5089520A (en) Method of inhibiting virus
US6001818A (en) Use of 2',3'-dideoxycytidin-2'-ene (2'- ,3'-dideoxy-2'3'-didehydrocytidine) in treating patients infected with retroviruses
US4423053A (en) Derivatives of 2-amino-5-(o-sulphamidophenyl)-1,3,4-thiadiazol as antiviral agents and a process for the preparation thereof
US5051498A (en) Lipophilic 2', 3'-dideoxynucleoside prodrug derivatives for the inhibition of replication of the AIDS virus and other retroviruses
US5043416A (en) Method of inhibiting virus
CA1327005C (en) Therapeutic nucleosides
CA2203672A1 (en) L-ribofuranosyl nucleosides